• Home
  • News
  • Brand Stories
  • Strategies
  • Brandz TV
  • Cover Stories
  • Magazine
  • Blog

  • Home
  • News
  • Brand Stories
  • Strategies
  • Brandz TV
  • Cover Stories
  • Magazine
  • Blog
HomeLatest NewsPadmaja Ruparel Highlights Funding Crisis in India’s Healthtech Sector at Startup Mahakumbh

Padmaja Ruparel Highlights Funding Crisis in India’s Healthtech Sector at Startup Mahakumbh

  • April 5, 2025
  • Brandz Editor Team
  • 0
Share on FacebookTweet on TwitterPinterestReddit
Post icon

India’s healthtech sector, once regarded as a booming industry, is currently grappling with a significant funding crisis. At the inaugural day of the Startup Mahakumbh event, Padmaja Ruparel, co-founder of the Indian Angel Network (IAN), highlighted the challenges faced by early-stage healthtech startups in securing capital within the domestic market. She warned that many promising startups are being forced to move overseas in search of better funding opportunities, which threatens the long-term growth and sustainability of the sector.

Table of Contents

Toggle
  • The Funding Drought in India’s Healthtech Sector
  • Early-Stage Startups Moving Overseas
  • The Need for Business and Financial Acumen
  • High Capital Demands and Limited Exit Opportunities
  • Conclusion

The Funding Drought in India’s Healthtech Sector

Despite the immense potential of the healthtech sector in India, the funding environment remains hostile, particularly for early-stage startups. In 2024, healthtech startups in India raised only $0.7 billion across 78 deals, a steep decline from previous years. The situation worsened in the first quarter of 2025, where funding totaled just $301 million. This amount was primarily driven by a single deal, Innovaccer’s $275 million funding round. This drop in investments highlights a growing concern for investors and entrepreneurs alike, signaling that the sector’s funding crisis is far from over.

Padmaja Ruparel’s remarks at the Startup Mahakumbh were a call to action for both entrepreneurs and investors to rethink their approach to funding and business development. She stressed that the sector’s promising innovations, especially in deep-tech solutions, are not enough to guarantee growth if they are not supported by a sound financial infrastructure.

Read Also:- Krutrim Accelerates Hiring Amid High-Profile Exits: Ola Group’s AI Venture Eyes Expansion

Early-Stage Startups Moving Overseas

One of the key issues facing healthtech startups in India is the lack of domestic capital, which has pushed many startups to look for funding opportunities in foreign markets. Ruparel highlighted that while the Indian government has launched initiatives to encourage startups, there is still a substantial gap in the capital available for early-stage ventures. This gap has forced entrepreneurs to explore opportunities abroad, where they often find more generous funding options and a more conducive environment for scaling their operations.

The increasing trend of early-stage healthtech startups moving abroad is a concerning development. Not only does it mean a loss of innovation within India, but it also results in missed opportunities for domestic investors to support groundbreaking technologies that could transform the healthcare landscape.

The Need for Business and Financial Acumen

Ruparel emphasized that, in order to thrive amidst this funding crisis, healthtech founders must prioritize business and financial acumen alongside their technological expertise. While technical innovation is at the core of healthtech, it is business strategy, financial planning, and sustainable growth models that will ultimately determine the success of a startup in today’s challenging environment.

Healthtech founders need to shift their focus from just developing groundbreaking technology to building scalable, revenue-generating business models. Startups must show potential investors that they are not just innovators, but also capable of managing finances and scaling operations efficiently.

High Capital Demands and Limited Exit Opportunities

Another issue raised by Ruparel was the high capital demands of healthtech startups. Developing healthcare technologies often requires significant upfront investments in research, development, and clinical trials. These costs can be a barrier for many early-stage companies, especially in a market where investors are hesitant to take risks on sectors that require long development cycles.

In addition to capital challenges, healthtech startups in India face limited exit opportunities. The lack of a robust merger and acquisition (M&A) ecosystem and public listing opportunities makes it harder for investors to realize returns on their investments. Without viable exit strategies, investors are less inclined to fund new ventures, contributing to the overall decline in funding for the sector.

Conclusion

The funding crisis in India’s healthtech sector is a pressing issue that demands immediate attention from both entrepreneurs and investors. As Padmaja Ruparel highlighted at the Startup Mahakumbh, the country’s early-stage healthtech startups are in danger of losing their competitive edge if they are unable to secure the necessary capital to fuel growth. To ensure the sustainability of this vital sector, entrepreneurs must embrace both technological innovation and sound business practices. Likewise, investors must recognize the immense potential of healthtech and work together to create a more conducive environment for early-stage startups to thrive. Only through collaboration and strategic investment can India’s healthtech sector rise to meet its full potential and drive meaningful change in the healthcare landscape.

Share this

Share on FacebookTweet on TwitterPinterestReddit

Related Posts

Honasa Consumer (Mamaearth) Sees 18% Decline in Q4 Profit Despite Revenue Growth
comments
Latest News

Honasa Consumer (Mamaearth) Sees 18% Decline in Q4 Profit Despite Revenue Growth

Pine Labs Transitions to Public Company Ahead of IPO
comments
Latest News

Pine Labs Transitions to Public Company Ahead of IPO

CloudSEK Raises $19 Million to Boost AI-Powered Cyber Threat Intelligence Platform
comments
Latest News

CloudSEK Raises $19 Million to Boost AI-Powered Cyber Threat Intelligence Platform

Comments

CURRENTLY ON STAND

FOLLOW US

Facebook 1,267Fans
Instagram 48Followers
Youtube 9Subscriber

RECENT POSTS

N-DESIGN: Pioneering Innovation, Transforming Communities

Starlink by Elon Musk Poised to Secure Approval for Commencing Operations in India

Starlink by Elon Musk Poised to Secure Approval for Commencing Operation...

Vahdam India Raises INR 25 Cr in Strategic Funding Round to Expand Its D2C Tea Business

Vahdam India Raises INR 25 Cr in Strategic Funding Round to Expand Its D...

    Home
    About Us
    Meet the team
    Work with Us
    Advertise With Us
    Submit Your Article
    Press Release
    Privacy
    Terms
    Contact
    Blog
Copyright © 2020 brandzmagazine.com ( A Brand Of Brands Accord LLP)
GET LATEST UPDATES

(Subscribe to our mailing list)